Risk of Liver Injury Associated with Chinese Herbal Products Containing Radix bupleuri in 639, 779 Patients with Hepatitis B Virus Infection

PLoS ONE

Volumn 6, Issue 1, 2011, Pages

  Lee, Chang Hsing ^a,b   Wang, Jung Der ^a,c,d   Chen, Pau Chung ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b Ton Yen General Hospital   (Taiwan)

^c NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CHINESE DRUG; LONG DAN XIE GAN TANG; UNCLASSIFIED DRUG; XIAO CHAI HU TANG; BUPLEURUM ROOT EXTRACT; HERBACEOUS AGENT; PLANT EXTRACT;

ADULT; AGED; ARTICLE; BUPLEURUM; CASE CONTROL STUDY; DOSE RESPONSE; HEPATITIS B; HUMAN; MAJOR CLINICAL STUDY; PRESCRIPTION; RISK ASSESSMENT; TAIWAN; TOXIC HEPATITIS; ADOLESCENT; FACTUAL DATABASE; FEMALE; HOSPITALIZATION; MALE; MIDDLE AGED; RISK;

HEPATITIS B VIRUS;

ADOLESCENT; ADULT; BUPLEURUM; DATABASES, FACTUAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG-INDUCED LIVER INJURY; DRUGS, CHINESE HERBAL; FEMALE; HEPATITIS B; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PLANT EXTRACTS; RISK; TAIWAN; YOUNG ADULT;

EID: 79955516343     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0016064     Document Type: Article

References (27)

1. Itoh S, Marutani K, Nishijima T, Matsuo S, Itabashi M, 1995, Liver injuries induced by herbal medicine, syo-saiko-to (xiao-chai-hu-tang). Dig Dis Sci. 40 (8): 1845-1848.
2. Borum ML, 2001, Fulminant exacerbation of autoimmune hepatitis after the use of ma huang. Am J Gastroenterol 96 (5): 1654-1655.
3. Park GJ, Mann SP, Ngu MC, 2001, Acute hepatitis induced by Shou-Wu-Pian, a herbal product derived from Polygonum multiflorum. J Gastroenterol Hepatol. 16 (1): 115-117.
4. Melchart D, Linde K, Weidenhammer W, Hager S, Shaw D, 1999, Liver enzyme elevations in patients treated with traditional Chinese medicine. JAMA 282 (1): 28-29.
5. Kane JA, Kane SP, Jain S, 1995, Hepatitis induced by traditional Chinese herbs; possible toxic components. Gut 36 (1): 146-147.
6. Allen BR, Hollman A, Jones R, Harper JI, Davies EG, 1990, Chinese herbs for eczema. Lancet 336 (8708): 177.
7. Lee CH, Chen JJ, Liang WM, 2006, Attitudes and intentions of patients toward integrated Chinese and Western medicine in Taiwan. J Altern Complement Med 12 (3): 233-236.
8. Chen FP, Kung YY, Chen YC, Jong MS, Chen TJ, Chen FJ, 2008, Frequency and pattern of Chinese herbal medicine prescriptions for chronic hepatitis in Taiwan. J Ethnopharmacol 117 (1): 84-91.
9. Chen CJ, Wang LY, Chien YC, 2004, News from Taiwan. Hepatology 39 (5): 1196.
10. Kamiyama T, Nouchi T, Kojima S, Murata N, Ikeda T, 1997, Autoimmune hepatitis triggered by administration of an herbal medicine. Am J Gastroenterol 92 (4): 703-704.
11. Mantani N, Kogure T, Sakai S, Goto H, Shibahara N, 2002, Incidence and clinical features of liver injury related to Kampo (Japanese herbal) medicine in 2, 496 cases between 1979 and 1999: problems of the lymphocyte transformation test as a diagnostic method. Phytomedicine 9 (4): 280-287.
12. Hsu LM, Huang YS, Tsay SH, Chang FY, Lee SD, 2006, Acute hepatitis induced by Chinese hepatoprotective herb, xiao-chai-hu-tang. J Chin Med Assoc 69 (2): 86-88.
13. Modi AA, Wright EC, Seeff LB, 2007, Complementary and alternative medicine (CAM) for the treatment of chronic hepatitis B and C: a review. Antivir Ther 12 (3): 285-295.
14. World health organization. 1999, WHO monographs on medicinal plants (Radix bupleuri), http://apps.who.int/medicinedocs/en/d/Js2200e/9.html#Js2200e.9. Accessed October 5, 2010.
15. Wong VW, Law MY, Hui AY, Lo AO, Li CY, 2005, A hospital clinic-based survey on traditional Chinese medicine usage among chronic hepatitis B patients. Complement Ther Med 13 (3): 175-182.
16. Larrey D, 2002, Epidemiology and individual susceptibility to adverse drug reactions affecting the liver. Semin Liver Dis 22 (2): 145-155.
17. Haller CA, Dyer JE, Ko R, Olson KR, 2002, Making a diagnosis of herbal-related toxic hepatitis. West J Med 176 (1): 39-44.
18. KC W, 2000, The Turnover Rate of Marker Constituents in Chinese Herbal Medicine. J Food Drug Anal 8: 270-277.
19. National Health Research Institutes. 2003, National Health Insurance Research database. http://www.nhri.org.tw/nhird/date_01.html#_edn1. Accessed January 3, 2009.
20. National Health Research Institutes. 2003, National Health Insurance Research database. http://www.nhri.org.tw/nhird/date_01.html#_edn1. Accessed January 8, 2010.
21. Centers for Disease Control and Prevention, Atlanta, Georgia, 1979, International Classification of Diseases, Ninth Revision (ICD-9). http://www.cdc.gov/nchs/icd/icd9.htm. Accessed October 18, 2009.
22. Centers for Disease Control. Department of Health, Taiwan. 2008, Guideline for Communicable Disease Surveillance. http://www.cdc.gov.tw/public/data/92271549671.pdf Accessed October 18, 2010.
23. MICROMEDEX 2006, Healthcare Series, Vol.127 [internet database]. Greenwood Village, CO Thomson Healthcare.
24. Deyo RA, Cherkin DC, Ciol MA, 1992, Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 45 (6): 613-619.
25. Ikegami F, Sumino M, Fujii Y, Akiba T, Satoh T, 2006, Pharmacology and toxicology of Bupleurum root-containing Kampo medicines in clinical use. Hum Exp Toxicol 25 (8): 481-494.
26. Yuen MF, Tam S, Fung J, Wong DK, Wong BC, 2006, Traditional Chinese medicine causing hepatotoxicity in patients with chronic hepatitis B infection: a 1-year prospective study. Aliment Pharmacol Ther 24 (8): 1179-1186.
27. Oka H, Yamamoto S, Kuroki T, Harihara S, Marumo T, 1995, Prospective study of chemoprevention of hepatocellular carcinoma with Sho-saiko-to (TJ-9). Cancer 76 (5): 743-749.